175 related articles for article (PubMed ID: 36864572)
1. Development of a prediction model for the acquisition of extended spectrum beta-lactam-resistant organisms in U.S. international travellers.
Brown DG; Worby CJ; Pender MA; Brintz BJ; Ryan ET; Sridhar S; Oliver E; Harris JB; Turbett SE; Rao SR; Earl AM; LaRocque RC; Leung DT
J Travel Med; 2023 Oct; 30(6):. PubMed ID: 36864572
[TBL] [Abstract][Full Text] [Related]
2. Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study.
Arcilla MS; van Hattem JM; Haverkate MR; Bootsma MCJ; van Genderen PJJ; Goorhuis A; Grobusch MP; Lashof AMO; Molhoek N; Schultsz C; Stobberingh EE; Verbrugh HA; de Jong MD; Melles DC; Penders J
Lancet Infect Dis; 2017 Jan; 17(1):78-85. PubMed ID: 27751772
[TBL] [Abstract][Full Text] [Related]
3. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies.
Lääveri T; Vlot JA; van Dam AP; Häkkinen HK; Sonder GJB; Visser LG; Kantele A
BMC Infect Dis; 2018 Jul; 18(1):341. PubMed ID: 30037325
[TBL] [Abstract][Full Text] [Related]
4. Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study.
Reuland EA; Sonder GJ; Stolte I; Al Naiemi N; Koek A; Linde GB; van de Laar TJ; Vandenbroucke-Grauls CM; van Dam AP
Clin Microbiol Infect; 2016 Aug; 22(8):731.e1-7. PubMed ID: 27223840
[TBL] [Abstract][Full Text] [Related]
5. Doxycycline as an antimalarial: Impact on travellers' diarrhoea and doxycycline resistance among various stool bacteria - Prospective study and literature review.
Kantele A; Mero S; Lääveri T
Travel Med Infect Dis; 2022; 49():102403. PubMed ID: 35872253
[TBL] [Abstract][Full Text] [Related]
6. Acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) carriage after exposure to systemic antimicrobials during travel: Systematic review and meta-analysis.
Wuerz TC; Kassim SS; Atkins KE
Travel Med Infect Dis; 2020; 37():101823. PubMed ID: 32755674
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolone antibiotic users select fluoroquinolone-resistant ESBL-producing Enterobacteriaceae (ESBL-PE) - Data of a prospective traveller study.
Kantele A; Mero S; Kirveskari J; Lääveri T
Travel Med Infect Dis; 2017; 16():23-30. PubMed ID: 28153711
[TBL] [Abstract][Full Text] [Related]
8. Role of gut microbiota in travel-related acquisition of extended spectrum β-lactamase-producing Enterobacteriaceae.
Peng Y; Liang S; Poonsuk K; On H; Li SW; Maurin MMP; Chan CH; Chan CL; Sin ZY; Tun HM
J Travel Med; 2021 Apr; 28(3):. PubMed ID: 33615366
[TBL] [Abstract][Full Text] [Related]
9. Intestinal colonization with extended-spectrum beta-lactamase producing Enterobacterales (ESBL-PE) during long distance travel: A cohort study in a German travel clinic (2016-2017).
Meurs L; Lempp FS; Lippmann N; Trawinski H; Rodloff AC; Eckardt M; Klingeberg A; Eckmanns T; Walter J; Lübbert C;
Travel Med Infect Dis; 2020; 33():101521. PubMed ID: 31770602
[TBL] [Abstract][Full Text] [Related]
10. Extended-spectrum β-lactamase-producing Enterobacteriaceae colonisation in long-term overseas business travellers.
Mizuno Y; Miura Y; Yamaguchi T; Matsumoto T
Travel Med Infect Dis; 2016; 14(6):561-567. PubMed ID: 27769900
[TBL] [Abstract][Full Text] [Related]
11. Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level.
Woerther PL; Andremont A; Kantele A
J Travel Med; 2017 Apr; 24(suppl_1):S29-S34. PubMed ID: 28520999
[TBL] [Abstract][Full Text] [Related]
12. High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors.
Kuenzli E; Jaeger VK; Frei R; Neumayr A; DeCrom S; Haller S; Blum J; Widmer AF; Furrer H; Battegay M; Endimiani A; Hatz C
BMC Infect Dis; 2014 Oct; 14():528. PubMed ID: 25270732
[TBL] [Abstract][Full Text] [Related]
13. Travel-associated multidrug-resistant organism acquisition and risk factors among US military personnel.
Buchek G; Mende K; Telu K; Kaiser S; Fraser J; Mitra I; Stam J; Lalani T; Tribble D; Yun HC
J Travel Med; 2021 Apr; 28(3):. PubMed ID: 33675647
[TBL] [Abstract][Full Text] [Related]
14. Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors.
Ostholm-Balkhed A; Tärnberg M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A;
J Antimicrob Chemother; 2013 Sep; 68(9):2144-53. PubMed ID: 23674762
[TBL] [Abstract][Full Text] [Related]
15. Colonization of patients hospitalized at orthopedic department of tertiary hospital in Uganda with extended-spectrum beta-lactamase-producing enterobacterales.
Bizimana J; Ndayisenga J; Kajumbura H; Mulepo P; Christine NF
Antimicrob Resist Infect Control; 2023 Apr; 12(1):26. PubMed ID: 37005681
[TBL] [Abstract][Full Text] [Related]
16. Duration of travel-associated faecal colonisation with ESBL-producing Enterobacteriaceae - A one year follow-up study.
ÖstholmBalkhed Å; Tärnberg M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A;
PLoS One; 2018; 13(10):e0205504. PubMed ID: 30356258
[TBL] [Abstract][Full Text] [Related]
17. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.
Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC
Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265
[TBL] [Abstract][Full Text] [Related]
18. International travel is a risk factor for extended-spectrum β-lactamase-producing Enterobacteriaceae acquisition in children: A case-case-control study in an urban U.S. hospital.
Strysko JP; Mony V; Cleveland J; Siddiqui H; Homel P; Gagliardo C
Travel Med Infect Dis; 2016; 14(6):568-571. PubMed ID: 27890813
[TBL] [Abstract][Full Text] [Related]
19. High carriage rate of ESBL-producing Enterobacteriaceae at presentation and follow-up among travellers with gastrointestinal complaints returning from India and Southeast Asia.
Barreto Miranda I; Ignatius R; Pfüller R; Friedrich-Jänicke B; Steiner F; Paland M; Dieckmann S; Schaufler K; Wieler LH; Guenther S; Mockenhaupt FP
J Travel Med; 2016 Feb; 23(2):tav024. PubMed ID: 26858272
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiome perturbation, antibiotic resistance, and Escherichia coli strain dynamics associated with international travel: a metagenomic analysis.
Worby CJ; Sridhar S; Turbett SE; Becker MV; Kogut L; Sanchez V; Bronson RA; Rao SR; Oliver E; Walker AT; Walters MS; Kelly P; Leung DT; Knouse MC; Hagmann SHF; Harris JB; Ryan ET; Earl AM; LaRocque RC
Lancet Microbe; 2023 Oct; 4(10):e790-e799. PubMed ID: 37716364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
